Literature DB >> 10833162

Bayesian communication: a clinically significant paradigm for electronic publication.

H P Lehmann1, S N Goodman.   

Abstract

OBJECTIVE: To develop a model for Bayesian communication to enable readers to make reported data more relevant by including their prior knowledge and values.
BACKGROUND: To change their practice, clinicians need good evidence, yet they also need to make new technology applicable to their local knowledge and circumstances. Availability of the Web has the potential for greatly affecting the scientific communication process between research and clinician. Going beyond format changes and hyperlinking, Bayesian communication enables readers to make reported data more relevant by including their prior knowledge and values. This paper addresses the needs and implications for Bayesian communication. FORMULATION: Literature review and development of specifications from readers', authors', publishers', and computers' perspectives consistent with formal requirements for Bayesian reasoning.
RESULTS: Seventeen specifications were developed, which included eight for readers (express prior knowledge, view effect size and variability, express threshold, make inferences, view explanation, evaluate study and statistical quality, synthesize multiple studies, and view prior beliefs of the community), three for authors (protect the author's investment, publish enough information, make authoring easy), three for publishers (limit liability, scale up, and establish a business model), and two for computers (incorporate into reading process, use familiar interface metaphors). A sample client-only prototype is available at http://omie.med.jhmi.edu/bayes.
CONCLUSION: Bayesian communication has formal justification consistent with the needs of readers and can best be implemented in an online environment. Much research must be done to establish whether the formalism and the reality of readers' needs can meet.

Mesh:

Year:  2000        PMID: 10833162      PMCID: PMC61428          DOI: 10.1136/jamia.2000.0070254

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  63 in total

1.  The philosophical limits of evidence-based medicine.

Authors:  M R Tonelli
Journal:  Acad Med       Date:  1998-12       Impact factor: 6.893

2.  How to keep up with the medical literature: II. Deciding which journals to read regularly.

Authors:  R B Haynes; K A McKibbon; D Fitzgerald; G H Guyatt; C J Walker; D L Sackett
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

3.  How to keep up with the medical literature: III. Expanding the number of journals you read regularly.

Authors:  R B Haynes; K A McKibbon; D Fitzgerald; G H Guyatt; C J Walker; D L Sackett
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

4.  Update on ONCOCIN: a chemotherapy advisor for clinical oncology.

Authors:  E H Shortliffe
Journal:  Med Inform (Lond)       Date:  1986 Jan-Mar

5.  Adjusting the number needed to treat: incorporating adjustments for the utility and timing of benefits and harms.

Authors:  R Riegelman; W S Schroth
Journal:  Med Decis Making       Date:  1993 Jul-Sep       Impact factor: 2.583

6.  A case for Bayesianism in clinical trials.

Authors:  D A Berry
Journal:  Stat Med       Date:  1993-08       Impact factor: 2.373

7.  The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care.

Authors:  L Bero; D Rennie
Journal:  JAMA       Date:  1995-12-27       Impact factor: 56.272

8.  A Bayesian approach to establishing sample size and monitoring criteria for phase II clinical trials.

Authors:  P F Thall; R Simon
Journal:  Control Clin Trials       Date:  1994-12

9.  Contrasting clinical and statistical significance within the research setting.

Authors:  B R Lindgren; C L Wielinski; S M Finkelstein; W J Warwick
Journal:  Pediatr Pulmonol       Date:  1993-12

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  4 in total

1.  Electronic publishing of scholarly communication in the biomedical sciences.

Authors:  W R Hersh; T C Rindfleisch
Journal:  J Am Med Inform Assoc       Date:  2000 May-Jun       Impact factor: 4.497

2.  Pharmacogenetics of anti-resorptive therapy efficacy: a Bayesian interpretation.

Authors:  Tuan V Nguyen
Journal:  Osteoporos Int       Date:  2005-02-01       Impact factor: 4.507

3.  Principles of Experimental Design for Big Data Analysis.

Authors:  Christopher C Drovandi; Christopher Holmes; James M McGree; Kerrie Mengersen; Sylvia Richardson; Elizabeth G Ryan
Journal:  Stat Sci       Date:  2017-08       Impact factor: 2.901

Review 4.  Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles.

Authors:  Kelley M Kidwell; Satrajit Roychoudhury; Barbara Wendelberger; John Scott; Tara Moroz; Shaoming Yin; Madhurima Majumder; John Zhong; Raymond A Huml; Veronica Miller
Journal:  Orphanet J Rare Dis       Date:  2022-05-07       Impact factor: 4.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.